Table 2.
Baseline clinical data of the study participants (n = 250) from antiretroviral Clinic at Gondar University Hospital, Northwest Ethiopia, 2012.
| Characteristics | Total n = 250 (%) | Tuberculosis negative n = 239 (%) | Tuberculosis positive* n = 11 (%) | p Value |
|---|---|---|---|---|
| Previous contact with TB | 26 (10) | 25 (11) | 1 (9) | 0.88 |
| History of TB treatment | 73 (29) | 69 (29) | 4 (36) | 0.59 |
| Alcohol drinking | 29 (12) | 27 (11) | 2 (18) | 0.49 |
| Tobacco use | 4 (2) | 4 (2) | 0 | 0.66 |
| Shisha use | 8 (3) | 7 (3) | 1 (9) | 0.26 |
| Receiving HAART | 167 (67) | 161 (67) | 6 (55) | 0.37 |
| Mean household members (IQR) | 3.8(2–5) | 3.7 | 5.4 | 0.52 |
| WHO clinical stage | ||||
| I | 126(50) | 122(51) | 4(37) | 0.63 |
| II | 39(16) | 36(15) | 3(27) | |
| III | 80(32) | 76(32) | 4(36) | |
| IV | 5(2) | 5(2) | 0 | |
| Current OIs | ||||
| Oral Thrush | 37 (15) | 36 (15) | 1 (9) | 0.59 |
| Pneumonia | 24 (10) | 21 (9) | 3 (27) | 0.04 |
| Herpes Zoster | 62 (25) | 60 (25) | 2 (18) | 0.60 |
| Chest X-ray findings | 61 (24) | 57 (24) | 4 (36) | 0.35 |
| Infiltrate | 14 (6) | 13 (5) | 1 (9) | 0.61 |
| Effusion | 7 (3) | 7 (3) | 0 | 0.56 |
| Cavity | 4 (2) | 4 (2) | 0 | 0.67 |
| Miliary | 2 (1) | 2 (1) | 0 | 0.76 |
TB – tuberculosis; HAART – highly active antiretroviral therapy; IQR – interquartile range; OIs – opportunistic infections; WHO – World Health Organization.
*
TB status was categorized based on the results of a combination of AFB smear microscopy, culture, RD9 and genus typing.